Whistleblower Exposes 3 Big Issues in Pfizer’s COVID Vaccine Clinical Trials

Save

By Xiaoxu Sean Lin, Ph.D. and Health 1+1

5/2/2022Updated: 10/25/2022

On Nov. 2, 2021 British Medical Journal (BMJ) published an article that revealed three big issues in Pfizer’s vaccine trial based on interview with a whistleblower.

The whistle blower, Brook Jackson, was a regional director of one of Pfizer’s vaccine trial companies, Ventavia Research Group in Texas.

Xiaoxu Sean Lin is an assistant professor in the Biomedical Science Department at Feitian College in Middletown, New York. He is also a frequent analyst and commentator for Epoch Media Group, VOA, and RFA. He is a veteran who served as a U.S. Army microbiologist and also a member of Committee on the Present Danger: China.

Author’s Selected Articles

The Flawed Logic in China’s Recent Statement Blaming the US for COVID Outbreak

Is Gain-of-Function Responsible for the Bird Flu Jump to Cows and Humans?

Promise or Peril: COVID-19 mRNA Vaccine Issues Series

FDA’s Failure to Safeguard the Public Resulted in Irreparable Erosion of Trust